Skip to main content
. 2012 Dec 7;5:42. doi: 10.1186/1757-2215-5-42

Table 1.

Baseline clinical and hormonal characteristics of the women with PCOS, women with H only and control groups

Parameters PCOS
H
Control
P
(n = 119) (n = 24) (n = 39) (overall)
Age (year)
22.2 ± 4.1
23.8 ± 4.9
24.4 ± 2.9
NS
BMI (kg/m2)
22.5 ± 3.1
22.1 ± 2.3
21.2 ± 2.08
NS
WHR
0.76 ± 0.06
0.77 ± 0.04
0.75 ± 0.06
NS
mFG
8.7 ± 5.3ª
10.0 ± 3.4ª
0.6 ± 0.9
<0.001
Testosterone (ng/dl)
70.4 ± 34.5ª
70.3 ± 30.7ª
34.9 ± 11.6
<0.001
SHBG (nmol/l)
39.6 ± 20.7ª
32.8 ± 16.7ª
56.5 ± 29.1
<0.001
FAI
8.8 ± 7.6ª
8.5 ± 4.5ª
2.7 ± 1.6
<0.001
DHEAS (μg/dl)
278 ±134b
314 ± 115ª
204 ± 74
<0.001
FPG (mg/dl)
82.4 ± 11.8
81.2 ± 10.7
83.7 ± 11.2
NS
Fasting insulin (μIU/ml)
11.1 ± 5.9
9.2 ± 3.5
9.4 ± 3.1
NS
HOMA-IR 2.3 ± 1.3 1.8 ± 0.7 1.9 ± 0.7 NS

Results are expressed as mean ± SD. NS not significant, BMI body mass index, WHR waist-to-hip ratio, mFG modified Ferriman-Gallwey score, SHBG sex hormone-binding globulin, FAI free androgen index, DHEAS dehydroepiandrosterone sulfate, FPG fasting plasma glucose, HOMA-IR homeostatic model assesment of insulin resistance.

a P <0.001 vs. Control.

b P <0.01 vs. Control.